195 related articles for article (PubMed ID: 26001247)
1. Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.
Hruska CB; Conners AL; Jones KN; O'Connor MK; Moriarty JP; Boughey JC; Rhodes DJ
AJR Am J Roentgenol; 2015 Jun; 204(6):1345-53. PubMed ID: 26001247
[TBL] [Abstract][Full Text] [Related]
2. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.
Rhodes DJ; Hruska CB; Conners AL; Tortorelli CL; Maxwell RW; Jones KN; Toledano AY; O'Connor MK
AJR Am J Roentgenol; 2015 Feb; 204(2):241-51. PubMed ID: 25615744
[TBL] [Abstract][Full Text] [Related]
3. A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.
Chen YS; Wang WH; Chan T; Sun SS; Kao A
Surg Oncol; 2002 Nov; 11(3):151-5. PubMed ID: 12356511
[TBL] [Abstract][Full Text] [Related]
4. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
Rhodes DJ; Hruska CB; Phillips SW; Whaley DH; O'Connor MK
Radiology; 2011 Jan; 258(1):106-18. PubMed ID: 21045179
[TBL] [Abstract][Full Text] [Related]
5. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
[TBL] [Abstract][Full Text] [Related]
6. Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue.
Shermis RB; Wilson KD; Doyle MT; Martin TS; Merryman D; Kudrolli H; Brenner RJ
AJR Am J Roentgenol; 2016 Aug; 207(2):450-7. PubMed ID: 27186635
[TBL] [Abstract][Full Text] [Related]
7. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
8. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
9. Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts.
Zhang Z; Wang W; Wang X; Yu X; Zhu Y; Zhan H; Chen Z; Li B; Huang J
Eur Radiol; 2020 Nov; 30(11):6062-6071. PubMed ID: 32524221
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi.
Hruska CB; Rhodes DJ; Collins DA; Tortorelli CL; Askew JW; O'Connor MK
J Womens Health (Larchmt); 2012 Jul; 21(7):730-8. PubMed ID: 22404787
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts.
Chae EY; Kim HH; Cha JH; Shin HJ; Kim H
J Ultrasound Med; 2013 Sep; 32(9):1573-8. PubMed ID: 23980217
[TBL] [Abstract][Full Text] [Related]
13. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Berg WA; Zhang Z; Lehrer D; Jong RA; Pisano ED; Barr RG; Böhm-Vélez M; Mahoney MC; Evans WP; Larsen LH; Morton MJ; Mendelson EB; Farria DM; Cormack JB; Marques HS; Adams A; Yeh NM; Gabrielli G;
JAMA; 2012 Apr; 307(13):1394-404. PubMed ID: 22474203
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
15. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.
Hruska CB; Weinmann AL; Tello Skjerseth CM; Wagenaar EM; Conners AL; Tortorelli CL; Maxwell RW; Rhodes DJ; O'Connor MK
Med Phys; 2012 Jun; 39(6):3476-83. PubMed ID: 22755727
[TBL] [Abstract][Full Text] [Related]
16. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
Berg WA; Blume JD; Cormack JB; Mendelson EB; Lehrer D; Böhm-Vélez M; Pisano ED; Jong RA; Evans WP; Morton MJ; Mahoney MC; Larsen LH; Barr RG; Farria DM; Marques HS; Boparai K;
JAMA; 2008 May; 299(18):2151-63. PubMed ID: 18477782
[TBL] [Abstract][Full Text] [Related]
17. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
18. Downstream imaging following abnormal molecular breast imaging, lessons learned and suggestions for success.
Maimone S; Hatcher KM; Tavana A; Robinson KA
Clin Imaging; 2022 Dec; 92():44-51. PubMed ID: 36191470
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
